chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain; shortness of breath and difficulty breathing; This is a spontaneous report from a contactable consumer (patient). A 90-year-old female patient received their first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date not reported), via an unspecified route of administration on the left arm on 11Jan2021 at single dose for COVID-19 immunization. Medical history included atrial fibrillation from an unknown date (AFib, diagnosed around 10 years ago), pulmonary issues from an unknown date and unknown if ongoing (pulmonary issues started within the last year), bad heart from an unknown date and unknown if ongoing.  There were no concomitant medications.  The patient experienced chest pain, shortness of breath and difficulty breathing on an unspecified date. The patient further reported that she has a lot of the symptoms that she lives with daily, she has a bad heart, has A Fib, has a pulmonary doctor and she discussed this with her doctor and they told her to go ahead and get the vaccination, so she went ahead with the vaccine, about 3-4 days later, got these chest pains, she has not had any chest pains connected to her Afib before, she also had shortness of breath and difficulty breathing 3-4 days after the vaccination, when she sat down and waited for this to pass, when it did pass, does not know if it was 5 min or 10 minutes, when that went away she felt very good. The patient also reported that she has not had any more chest pains since the first episode, she is still struggling with the difficulty breathing but unsure if this is just her body and prior conditions or due to the vaccine. Does not know what it was, thought maybe she had a heart attack, wants to know if she should go ahead and get the second vaccine. Does not want to get any of the side effects worse than what she had, states someone told her the second one hits you harder and wants to know if this is true. The patient did not recover from shortness of breath and difficulty breathing while the outcome of the rest of the events was unknown.  Information on the batch number/lot number  has been requested
This is a spontaneous report received from noncontactable consumer or other non-HCP. A male patient received the 4th dose (second booster) of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunization. Medical history and concomitant medications not reported. Vaccination history included the 1st, 2nd and 3rd (first booster) of the COVID-19 vaccine (manufacturer unknown), for immunization. The patient experienced inflammation (inflammatory issues), with outcome of unknown. Relevant laboratory tests and procedures available in the appropriate section. Additional information: The caller stated their father got the 4th dose of Pfizer COVID-19 vaccine. He and his doctors suspect the vaccine may have caused some sort of autoimmune issue in his body. He is concerned about his increased blood cell counts. He is seeing a hematologist now doing tests for leukemia. The caller stated they called to report his side effects of vaccination, and to ask if Pfizer has any specialist/doctor to refer the patient for the treatment of inflammatory issues. Caller referred back to their father's PCP or hematologist, as Pfizer is unable to make any specific treatment recommendations for individual patients. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
10/17/16 12:30 Employee is here to report reaction from flu vaccine she received 10/12/16. 10/12/16 - Wednesday afternoon - sneezing, nose running and congestion. She also had headache, burning eyes, pain eyes, body ache, lack of appetite, felt feverish off and on, chills, scratchy throat, swollen lymph node jaw site under ear. She C/O sharp pain on her chest on and off. Following day 10/13/16 - shooting pain, RT rib pain and abdominal pain and fatigue. 10/17/16 - nasal drainage, fatigue, hot flashes, sinus pressure.
6/22/21 first dose of Pfizer Vaccine 6/25/21 Chest Pain 7/2/21 Seek medical attention at ER/Urgent
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 14-year-old male patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 07-NOV-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
severe left arm pain with axillary lymphadenopathy and extensive left sided cervical lymphadenopathy
Severe joint pain throughout the entire body.  Muscles around knees are so tight I can barely bend them, and when I do; it causes severe pain.  Pain continues over two weeks after injection.  I can barely walk at times.
Headache, nausea, muscle aches, fever 102, back pain radiating to sides, injection site very painful, bladder pain-urgency on day 3 so far not better.
On 8/17/01 at 17:30, pt was immunized. At 18:30, pt developed a temperature of 101F. On 8/18/01 at 02:30, took to ER with temperature of 103.7F and a seizure and was admitted to hospital. Pt was started on IV anti-seizure medicines. On 8/20/01, pt was discharged from hospital.
After the vaccination I went to work and began feeling ill. I began experiencing headaches, fatigue, and brain fog. The vaccination was on Monday, 3/13/2023 and my symptoms amplified. On Wednesday, 3/15/2023, I felt the worst, and had to go home early. The main symptoms were fatigue, upset stomach, diarrhea, hemorrhoids, and headaches. Those symptoms lasted approximately for 5 additional days, and then subsided. I still have headaches. I went to the clinic and informed them of my symptoms. The clerk advised me to file a VAERS report and mention my symptoms to the medical professional during a prescheduled medical appointment for March 13, 2023.
1756 Pt c/o itchy throat. Vitals taken.  1758 Team alert called. 1759 c/o tingling in fingers  . c/o shortness of breath and not feeling well.  MD arrived.
her left ear is full; feeling pressure; tinnitus; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   Reporter did not allow further contact.
5 x4 1/2 cm red, warm skin lesion on the upper Rt thigh. No limping, seems fine, no fever, no adenopathy. Local reaction.
This is a spontaneous report from a non-contactable consumer. This 44-year-old female consumer (patient) reported for herself that: A patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection and Batch/Lot Number: EW0187), dose 1 via an unspecified route of administration, administered in Arm Right on Jun2021 at 02:00 PM as DOSE 1, SINGLE for Covid-19 Immunisation. Medical history included Thyroidectomy, Food Sensitivities, Allergies to cashew, Allergies to peanuts, Allergies to gluten, Allergies to wheat, Penicillin allergy, Hair dye sensitivity from unknown date and unknown if ongoing. Concomitant medication(s) included SYNTHROID 100 Mg taken for an unspecified indication, start and stop date were not reported. Patient did not suffer from COVID prior vaccination and patient did not COVID tested post vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced Anaphylaxis on 05Jun2021, within 2 minutes my arm began to burn, Hot flash, and My neck began to tighten by 3 minutes on 05Jun2021. Benadryl was received as treatment for all the events. There was no other vaccine in four weeks. On unspecified date in 2021, the events were resolved with sequelae. No follow-up attempts are possible. No further information is expected.
sibling w/chicken pox 2 1/2 wks prior to incident-mom called MD office to report fever 101 & rash of approx 20 spots;seen in office dx confirmed, zovirax given;
Received 3 Doses of Hepatitis Vaccine (Heplisav, Engerix, Heplisav); Initial Report Received on 08-Apr-2022  A pharmacist reported that a 68 year-old male (race and ethnicity not provided) received HEPLISAV-B (hepatitis B vaccine) for the first dose of hepatitis B immunization. The second dose was Engerix, and the third dose was HEPLISAV-B.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On 08-Oct-2021, the patient received the first dose of HEPLISAV-B (Lot # 934975, expiration date 15-Aug-2022, NDC # 43528-003-05, Serial Number Unknown) in the left deltoid from a pharmacist.  In Nov-2021, 1 month after being vaccinated with HEPLISAV-B, the patient received the second dose of a hepatitis B vaccine, Engerix, from the pharmacist.  On 08-Apr-2022, the patient received a third dose hepatitis B vaccine, HEPLISAV-B (Lot # 937231, expiration date 30-Jan-2023, NDC # 43528-003-05, Serial Number 971303248430), in the left deltoid from the pharmacist.  The patient did not experience adverse reactions. No additional information was reported.   Company Comment: The company assessed the events as non-serious.; Sender's Comments: The company assessed the events as non-serious.
C/o pain around rt arm, including axilla starting about 11:30a on 12/8/99.Also c/o numbness rt little finger & 4th finger beginning 12/9/99.
One week of swollen arm - hot, pain, fever, fatigue - 2 days later active outbreak of shingles on left leg.
27AUG92 father reported pt had fever of 103, rash on back, chills, & shaking (not sz) on evening of 26OCT92 following vax that day; MD advised father to given APAP;
Information has been received from a physician concerning a 4 year old male with no allergies or medical conditions, who on 4/24/02 was vaccinated SC with the first dose of varicella virus vaccine live (lot # 640724/0059M). There were no concomitant medications. At the time of vaccination, the patient had normal appetite and normal activity. Beginning on 6/26/04 at 11:30 AM, the patient developed breakthrough varicella. Unspecified medical attention was sought. No laboratory or diagnostic studies were performed. The patient was given acyclovir suspension. A product quality complaint was not involved. Follow up information received from the patient's mother indicated that the patient had 20 to 30 small erythemic maculopapular lesions over the upper and inner thighs and forearms. It was also reported that the patient was given acyclovir to make him less contagious to his immunocompromised brother. It was reported that the patient recovered. Additional information is not expected.
Patient states that they have had no side effects or adverse events.  Vaccine was given from vial that had been in refrigerator longer than 30 days
I had a fever and chills for several hours after the vaccine. Then, not long after the end of November my blood pressure spiked, and my heartrate went way up. I had to go the emergency room because I thought I was having a heart attack. They monitored me and gave me a medication that lowered my blood pressure. I am unable to recall the medication name though. I am doing much better now.
extreme Chills followed by being very Hot and then chills again , headache , teeth hurt , eyes sensitive to light and eye balls aching  and still are ,temperature 3rd day morning 100.2 never checked on 2nd day. Shot in the arm hurt 1 st day where a 1st doze shot did not hurt till next day, nausea,  weakness all  over and joints hurt.  I took1/2 of 2 percocets  1half every 3 hours for 12 hours and that helped with headache and teeth..tylenol did not help headache and I never have headaches.  I thought I was dying.  I spoke to friends who have had 2nd dose and most experienced some but not all and many nothing after 2nd dose.
This case was reported by a consumer via call center representative and described the occurrence of itchy rash in a 58-year-old female patient who received SHINGRIX for prophylaxis. On 27th August 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. On 28th August 2018, 1 days after receiving SHINGRIX, the patient experienced itchy rash. The patient was treated with non-drug therapy (Cold Compresses) and diphenhydramine hydrochloride (Benadryl). On an unknown date, the outcome of the itchy rash was recovered/resolved. It was unknown if the reporter considered the itchy rash to be related to SHINGRIX. Additional details were provided as follows: The patient reported that she started having the symptoms the day after the SHINGRIX vaccine. She had an itchy rash that covered her all upper arm on the same arm where she had the SHINGRIX vaccine. The patient had to use cold compresses and take Benadryl to treat it. The rash was 4 by 4 inches, just to the right of her injection site and it lasted about 5 days. The patient provided contact details of her physician and consented to follow up.
no symptoms / signs immediately after 4p vaccination. Then the following morning upon wake up pt was very sad, and inconsolable. Stating he didn't feel good and his leg hurt. When you would pick him up he would yell in pain if you touched his left leg (injection site). He was feverish and sitting / unable to walk. Then the next morning 9/3/23 He woke up feeling better still slightly feverish but no longer inconsolable and able to play but his leg was swollen and stiff unable to bend his knee he walked with a lim all day.  This continued until the following day when some mobility returned but he was still noticeably limping.
Rash, morbilloform and over entire body--4-5mm papules become confluent, starting around 6 days post vaccination progressing to severe pruritic rash on day 8.  No other symptoms of note
chest really tight; shortness of breath; heart is beating faster; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (chest really tight), DYSPNOEA (shortness of breath) and TACHYCARDIA (heart is beating faster) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J2LA) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Dec-2021, the patient experienced CHEST DISCOMFORT (chest really tight), DYSPNOEA (shortness of breath) and TACHYCARDIA (heart is beating faster). At the time of the report, CHEST DISCOMFORT (chest really tight) and DYSPNOEA (shortness of breath) had not resolved and TACHYCARDIA (heart is beating faster) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Dec-2021, Heart rate: high (High) heart is beating faster.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported. No treatment drug details was reported.
Information has been received from a physician concerning a 24 year old female who on 22-OCT-2010 was intramuscularly vaccinated with a second dose of GARDASIL (lot # "10172"). After receiving vaccine, the patient reported that her arm was sore and swollen. The physician had prescribed the patient BENADRYL. On 02-NOV-2010, the patient called the doctor's office stating that the diphenhydramine hydrochloride did not work and that her arm hurt even worse, with pain extending from her shoulder to her finger. The patient stated that she was not able to use her arm. She was then sent to urgent care (location and duration unspecified) and was given ibuprofen and a muscle relaxer. No diagnostic laboratory tests were performed. On 03-NOV-2010 the patient called said she was slightly better but not recovered. According to the reporter the patient's arm sore and swollen were considered to be disabling. The reporter also considered that the events were other important medical event since the patient "was treated with diphenhydramine hcl and a muscle relaxer." Additional information has been requested.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and/or zoster-related conditions. Subsequent to patient's zoster vaccine live (ZOSTAVAX) inoculation in the pharmacy, patient was treated by the physician, for shingles. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age. On unknown dates the patients were vaccinated with doses of improperly stored (Oka/Merck) VARIVAX. No adverse experiences were reported. This is one of several reports received from the same source. Additional information has been requested.
She received the MMR vacination on December 12, 2006 and on December 20, 2006 in the p.m. she started breaking out in these small red, slightly raised, red bumps. They were about as big as a pencil eraser head.  I did not think too much about it she had a few on her stomach and a couple on her leg.  I noticed these when I was putting her down for the night on the 20th.  She had been playing with the Christmas tree branches and I thought these were marks from the branches.  She is fair skinned and marks easily.  The next morning when I changed her diaper, she was covered in hives.  The places that were just small red bumps the night before were now these large red welts.  I called Dr's office and they got me right in that morning.  He diagnosed them as hives and said more than likely they were a reaction to the MMR shot.  He recommended Benadryl 1/4 teaspoon.  These were completely gone by 12/26/2006.
patient experienced rash in groin area, trunk , and arms starting 48 hours after vaccine admin. patient also experienced swelling around the eyes.   patient recognized symptoms and began diphenhydramine 25mg for 4 consecutive doses starting friday 10/09/20 through sat 10/10/20. Syptoms resolved over the next 48 hours. patient came to pharmacy 10/20/20 to report adverse event
Received second dose of Pfizer vaccine on 1/7/21.  (first dose lot EK5730, second dose EK9231).  After second dose, caregiver had muscle aches, body chills and HA for about 36 hours after.  These had generally resolved by 1/10/21.  On 1/11/21, caregiver awoke with intense pain in Left hand/thumb and not able to grip with  left hand.  This pain has waxed and waned over the last 3 days, with some improvement, but not resolution of the symptoms.  The pain has radiated up  left arm to my shoulder, but is mostly focused in the thumb/wrist area.  Caregiver have had no acute injury to this location and no change in activity level.  Both of vaccine injections were in the Left Delt.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID:  The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in May2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 Immunization. The following information was reported: BLOOD PRESSURE INCREASED (non-serious) with onset 2022, outcome "unknown", described as "Elevated blood pressure"; LIMB DISCOMFORT (non-serious) with onset 2022, outcome "not recovered", described as "My arm has been greatly effected/ it is getting worse"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 2022, outcome "not recovered" and all described as "Numbness and tingling is now all the way down in my fingers"; MOVEMENT DISORDER (non-serious), outcome "not recovered", described as "Effecting my left hand movements". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: It was reported that the patient received the booster back in May2022 and the patient's arm had been greatly effected ever since. There appeared to be no sign of improvement. To be more precise it was getting worse. As a piano player it had been effecting its left hand movements. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient states she started to decline after vaccine,  increased weakness, and  platelet count significantly decreased.